Debating the Risks of Animal-to-Human Organ Transplants
Executive SummaryDebate continues swirling around the issues of animal-to-human organ transplant, stirring up ethical concerns as well as scientific ones. This much is certain: the companies involved in the area saw potential problems coming a long time ago, but placed bets they hoped would establish them as leaders in a new and lucrative market. Those bets may yet pay off, but the players will now be watched far more closely than they were just a few years ago.
You may also be interested in...
Increasing savvy around cybersecurity issues is driving regulators and trade groups to update their approach to the area, speakers from the US FDA and the American Medical Association said at this week’s FDA/CMS Summit.
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.